We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intelligent Ultrasound Group Plc | LSE:IUG | London | Ordinary Share | GB00BN791Q39 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 1.82% | 8.40 | 8.00 | 8.80 | 8.50 | 8.25 | 8.25 | 31,137 | 10:32:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 10.1M | -2.98M | -0.0091 | -9.23 | 27.46M |
TIDMIUG
RNS Number : 6898X
Intelligent Ultrasound Group PLC
22 December 2023
Intelligent Ultrasound Group plc
("the Company")
Grant of Share Options
Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces the grant of 2,649,015 share options to the Directors and 6,800,332 share options to other management and employees (together the "options") on 21 December 2023 at a price of 9.6 pence per share, representing the closing mid-market price on 20 December 2023, the date of approval by the Remuneration Committee.
Individual Director option grants
Director New grant Type Stuart Gall 530,428 EMI ---------- -------- Stuart Gall 501,322 Non-EMI ---------- -------- Nicholas Sleep 450,297 Non-EMI ---------- -------- Nicholas Sleep 530,428 EMI ---------- -------- Helen Jones 334,409 Non-EMI ---------- -------- Helen Jones 302,131 EMI ---------- --------
Following the option grants above, the Directors hold the total number of share options as shown below:
Director Number of options held Stuart Gall 4,880,048 ----------------------- Nicholas Sleep 3,879,436 ----------------------- Helen Jones 2,298,806 ----------------------- 11,058,490 ----------------------- % of share capital on fully diluted basis 3.1% -----------------------
Vesting criteria for all options
The share options vest equally over three years i.e. one third on the first, second and third anniversary of issue, subject to the grantee's continued service with the Group and will remain exercisable at any point up until the tenth anniversary of the date of grant.
Number of shares in respect of which the Option shall vest 1/3 vest after 12 months 1/3 vest after a further 12 months 1/3 vest after a further 12 months
Management and employee options
A total of 6,800,332 options have been issued to other management and employees. These option grants are under the Company's EMI scheme where the individual and the grant meets EMI criteria. Grants which do not qualify are under the same rules as the EMI scheme but will not benefit from EMI tax status.
The notification in Appendix 1 to this announcement, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
For further information, please contact:
Intelligent Ultrasound Group plc www.intelligentultrasound.com Stuart Gall, CEO Tel: +44 (0)29 2075 6534 Helen Jones, CFO Cavendish Capital Markets Limited - Nominated Adviser and Broker Giles Balleny/Dan Hodkinson (Corporate Tel: +44 (0)20 7220 0500 Finance) Michael Johnson/Julian Morse (Sales) Nigel Birks (ECM) TB Cardew - PR Advisors Intelligentultrasound@tbcardew.com Ed Orlebar Tel: +44 (0)7738 724630 Allison Connolly Tel: +44 (0)7587 453955 Emma Pascoe-Watson Tel: +44 (0)7774 620415
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,500 simulators have been sold to over 750 medical institutions around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the FDA, but is not available for sale in any other territory requiring government approval for this type of product.
Appendix 1
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES 1 Details of the person discharging managerial responsibilities / person closely associated ------------------------------------------------------------------------ a) Name Stuart Gall -------------------------------- -------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------ a) Position/status Chief Executive Officer -------------------------------- -------------------------------------- b) Initial notification/amendment Initial notification -------------------------------- -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------ a) Full name of the entity Intelligent Ultrasound Group plc -------------------------------- -------------------------------------- b) Legal entity identifier code 213800K4ZVWL4ZYQAZ70 -------------------------------- -------------------------------------- 4 Details of the transaction(s) ------------------------------------------------------------------------ a) Description of the financial Options over ordinary shares in instrument, type of instrument Intelligent Ultrasound Group plc with a nominal value of 1 pence each -------------------------------- -------------------------------------- b) Identification Code ISIN: GB00BN791Q39 -------------------------------- -------------------------------------- c) Nature of the transaction Grant of options over Ordinary Shares -------------------------------- -------------------------------------- d) Currency GBP - British pound -------------------------------- -------------------------------------- e) Price(s) and Volume(s) Price - 9.6 pence Volume - 1,031,750 -------------------------------- -------------------------------------- f) Aggregated information N/A * Price * Volume * Total -------------------------------- -------------------------------------- g) Date of transaction 21 December 2023 -------------------------------- -------------------------------------- h) Place of transaction Off market -------------------------------- -------------------------------------- NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES 1 Details of the person discharging managerial responsibilities / person closely associated ------------------------------------------------------------------------ a) Name Nicholas Sleep -------------------------------- -------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------ a) Position/status Chief Technical Officer -------------------------------- -------------------------------------- b) Initial notification/amendment Initial notification -------------------------------- -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------ a) Full name of the entity Intelligent Ultrasound Group plc -------------------------------- -------------------------------------- b) Legal entity identifier code 213800K4ZVWL4ZYQAZ70 -------------------------------- -------------------------------------- 4 Details of the transaction(s) ------------------------------------------------------------------------ a) Description of the financial Options over ordinary shares in instrument, type of instrument Intelligent Ultrasound Group plc with a nominal value of 1 pence
each -------------------------------- -------------------------------------- b) Identification Code ISIN: GB00BN791Q39 -------------------------------- -------------------------------------- c) Nature of the transaction Grant of options over Ordinary Shares -------------------------------- -------------------------------------- d) Currency GBP - British pound -------------------------------- -------------------------------------- e) Price(s) and Volume(s) Price - 9.6 pence Volume - 980,725 -------------------------------- -------------------------------------- f) Aggregated information N/A * Price * Volume * Total -------------------------------- -------------------------------------- g) Date of transaction 21 December 2023 -------------------------------- -------------------------------------- h) Place of transaction Off market -------------------------------- -------------------------------------- NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES 1 Details of the person discharging managerial responsibilities / person closely associated ------------------------------------------------------------------------ a) Name Helen Jones -------------------------------- -------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------ a) Position/status Chief Financial Officer -------------------------------- -------------------------------------- b) Initial notification/amendment Initial notification -------------------------------- -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------ a) Full name of the entity Intelligent Ultrasound Group plc -------------------------------- -------------------------------------- b) Legal entity identifier code 213800K4ZVWL4ZYQAZ70 -------------------------------- -------------------------------------- 4 Details of the transaction(s) ------------------------------------------------------------------------ a) Description of the financial Options over ordinary shares in instrument, type of instrument Intelligent Ultrasound Group plc with a nominal value of 1 pence each -------------------------------- -------------------------------------- b) Identification Code ISIN: GB00BN791Q39 -------------------------------- -------------------------------------- c) Nature of the transaction Grant of options over Ordinary Shares -------------------------------- -------------------------------------- d) Currency GBP - British pound -------------------------------- -------------------------------------- e) Price(s) and Volume(s) Price - 9.6 pence Volume - 636,540 -------------------------------- -------------------------------------- f) Aggregated information N/A * Price * Volume * Total -------------------------------- -------------------------------------- g) Date of transaction 21 December 2023 -------------------------------- -------------------------------------- h) Place of transaction Off market -------------------------------- --------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFELFWFEDSEIE
(END) Dow Jones Newswires
December 22, 2023 02:00 ET (07:00 GMT)
1 Year Intelligent Ultrasound Chart |
1 Month Intelligent Ultrasound Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions